Work

Abstract B023: Harnessing the dual therapeutic approach of CRISPR/CAS9 and CAR-T cell technologies in KRAS mutated solid tumors

Year: 2025
Type: conference-abstract
Language: English
Open Access status: closed
OpenAlex ID: W4407052433
Cites:
Cited by:
Related to: 10